Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction.
Identifieur interne : 000548 ( Main/Exploration ); précédent : 000547; suivant : 000549Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction.
Auteurs : Parul U. Gandhi [États-Unis] ; Sheryl L. Chow [États-Unis] ; Thomas S. Rector [États-Unis] ; Henry Krum [Australie] ; Hanna K. Gaggin [États-Unis] ; John J. Mcmurray [Royaume-Uni] ; Michael R. Zile [États-Unis] ; Michel Komajda [France] ; Robert S. Mckelvie [Canada] ; Peter E. Carson [États-Unis] ; James L. Januzzi [États-Unis] ; Inder S. Anand [États-Unis]Source :
- Journal of cardiac failure [ 1532-8414 ] ; 2017.
Descripteurs français
- KwdFr :
- Antagonistes du récepteur de type 1 de l'angiotensine-II (usage thérapeutique), Cause de décès (tendances), Débit systolique (physiologie), Défaillance cardiaque (mortalité), Défaillance cardiaque (sang), Défaillance cardiaque (traitement médicamenteux), Dérivés du biphényle (usage thérapeutique), Facteurs de risque, Facteurs temps, Femelle, Hospitalisation (), Humains, Mâle, Pronostic, Protéines de liaison aux IGF (sang), Sujet âgé, Taux de survie (tendances), Tétrazoles (usage thérapeutique), États-Unis d'Amérique (épidémiologie), Études de suivi.
- MESH :
- mortalité : Défaillance cardiaque.
- physiologie : Débit systolique.
- sang : Défaillance cardiaque, Protéines de liaison aux IGF.
- tendances : Cause de décès, Taux de survie.
- traitement médicamenteux : Défaillance cardiaque.
- usage thérapeutique : Antagonistes du récepteur de type 1 de l'angiotensine-II, Dérivés du biphényle, Tétrazoles.
- épidémiologie : États-Unis d'Amérique.
- Facteurs de risque, Facteurs temps, Femelle, Hospitalisation, Humains, Mâle, Pronostic, Sujet âgé, Études de suivi.
English descriptors
- KwdEn :
- Aged, Angiotensin II Type 1 Receptor Blockers (therapeutic use), Biphenyl Compounds (therapeutic use), Cause of Death (trends), Female, Follow-Up Studies, Heart Failure (blood), Heart Failure (drug therapy), Heart Failure (mortality), Hospitalization (statistics & numerical data), Humans, Insulin-Like Growth Factor Binding Proteins (blood), Male, Prognosis, Risk Factors, Stroke Volume (physiology), Survival Rate (trends), Tetrazoles (therapeutic use), Time Factors, United States (epidemiology).
- MESH :
- chemical , blood : Insulin-Like Growth Factor Binding Proteins.
- chemical , therapeutic use : Angiotensin II Type 1 Receptor Blockers, Biphenyl Compounds, Tetrazoles.
- blood : Heart Failure.
- drug therapy : Heart Failure.
- epidemiology : United States.
- mortality : Heart Failure.
- physiology : Stroke Volume.
- statistics & numerical data : Hospitalization.
- trends : Cause of Death, Survival Rate.
- Aged, Female, Follow-Up Studies, Humans, Male, Prognosis, Risk Factors, Time Factors.
Abstract
The prognostic merit of insulin-like growth factor-binding protein 7 (IGFBP7) is unknown in heart failure and preserved ejection fraction (HFpEF).
DOI: 10.1016/j.cardfail.2016.06.006
PubMed: 27317843
Affiliations:
- Australie, Canada, France, Royaume-Uni, États-Unis
- Californie, Caroline du Sud, Connecticut, District de Columbia, Massachusetts, Minnesota, Victoria (État), Île-de-France
- Melbourne, Paris
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001284
- to stream PubMed, to step Curation: 001273
- to stream PubMed, to step Checkpoint: 001273
- to stream Ncbi, to step Merge: 003729
- to stream Ncbi, to step Curation: 003729
- to stream Ncbi, to step Checkpoint: 003729
- to stream Main, to step Merge: 000543
- to stream Main, to step Curation: 000548
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction.</title><author><name sortKey="Gandhi, Parul U" sort="Gandhi, Parul U" uniqKey="Gandhi P" first="Parul U" last="Gandhi">Parul U. Gandhi</name><affiliation wicri:level="2"><nlm:affiliation>Section of Cardiovascular Medicine, VA Connecticut, West Haven, Connecticut; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Connecticut</region></placeName><wicri:cityArea>Section of Cardiovascular Medicine, VA Connecticut, West Haven, Connecticut; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven</wicri:cityArea></affiliation></author><author><name sortKey="Chow, Sheryl L" sort="Chow, Sheryl L" uniqKey="Chow S" first="Sheryl L" last="Chow">Sheryl L. Chow</name><affiliation wicri:level="2"><nlm:affiliation>Western University of Health Sciences, Pomona, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Western University of Health Sciences, Pomona</wicri:cityArea></affiliation></author><author><name sortKey="Rector, Thomas S" sort="Rector, Thomas S" uniqKey="Rector T" first="Thomas S" last="Rector">Thomas S. Rector</name><affiliation wicri:level="2"><nlm:affiliation>Veterans Affairs Medical Center, Minneapolis, Minnesota; University of Minnesota, Minneapolis, Minnesota.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Minnesota</region></placeName><wicri:cityArea>Veterans Affairs Medical Center, Minneapolis, Minnesota; University of Minnesota, Minneapolis</wicri:cityArea></affiliation></author><author><name sortKey="Krum, Henry" sort="Krum, Henry" uniqKey="Krum H" first="Henry" last="Krum">Henry Krum</name><affiliation wicri:level="3"><nlm:affiliation>CCRE Therapeutics, Monash University, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>CCRE Therapeutics, Monash University, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Gaggin, Hanna K" sort="Gaggin, Hanna K" uniqKey="Gaggin H" first="Hanna K" last="Gaggin">Hanna K. Gaggin</name><affiliation wicri:level="2"><nlm:affiliation>Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Cardiology Division, Massachusetts General Hospital, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Mcmurray, John J" sort="Mcmurray, John J" uniqKey="Mcmurray J" first="John J" last="Mcmurray">John J. Mcmurray</name><affiliation wicri:level="1"><nlm:affiliation>British Heart Foundation Glasgow Cardiovascular Research Center, Glasgow, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>British Heart Foundation Glasgow Cardiovascular Research Center, Glasgow</wicri:regionArea><wicri:noRegion>Glasgow</wicri:noRegion></affiliation></author><author><name sortKey="Zile, Michael R" sort="Zile, Michael R" uniqKey="Zile M" first="Michael R" last="Zile">Michael R. Zile</name><affiliation wicri:level="2"><nlm:affiliation>RHJ Department of Veterans Affairs Medical Center and Medical University of South Carolina, Charleston, South Carolina.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Caroline du Sud</region></placeName><wicri:cityArea>RHJ Department of Veterans Affairs Medical Center and Medical University of South Carolina, Charleston</wicri:cityArea></affiliation></author><author><name sortKey="Komajda, Michel" sort="Komajda, Michel" uniqKey="Komajda M" first="Michel" last="Komajda">Michel Komajda</name><affiliation wicri:level="3"><nlm:affiliation>Université Paris 6; Pitie Salpetriere Hospital, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université Paris 6; Pitie Salpetriere Hospital, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Mckelvie, Robert S" sort="Mckelvie, Robert S" uniqKey="Mckelvie R" first="Robert S" last="Mckelvie">Robert S. Mckelvie</name><affiliation wicri:level="1"><nlm:affiliation>Population Health Research Institute and McMaster University, Hamilton, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Population Health Research Institute and McMaster University, Hamilton, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Carson, Peter E" sort="Carson, Peter E" uniqKey="Carson P" first="Peter E" last="Carson">Peter E. Carson</name><affiliation wicri:level="2"><nlm:affiliation>Washington VAMC and Georgetown University, Washington, DC.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">District de Columbia</region></placeName><wicri:cityArea>Washington VAMC and Georgetown University, Washington</wicri:cityArea></affiliation></author><author><name sortKey="Januzzi, James L" sort="Januzzi, James L" uniqKey="Januzzi J" first="James L" last="Januzzi">James L. Januzzi</name><affiliation wicri:level="2"><nlm:affiliation>Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: jjanuzzi@partners.org.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Cardiology Division, Massachusetts General Hospital, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Anand, Inder S" sort="Anand, Inder S" uniqKey="Anand I" first="Inder S" last="Anand">Inder S. Anand</name><affiliation wicri:level="2"><nlm:affiliation>Veterans Affairs Medical Center, Minneapolis, Minnesota; University of Minnesota, Minneapolis, Minnesota.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Minnesota</region></placeName><wicri:cityArea>Veterans Affairs Medical Center, Minneapolis, Minnesota; University of Minnesota, Minneapolis</wicri:cityArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:27317843</idno><idno type="pmid">27317843</idno><idno type="doi">10.1016/j.cardfail.2016.06.006</idno><idno type="wicri:Area/PubMed/Corpus">001284</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001284</idno><idno type="wicri:Area/PubMed/Curation">001273</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001273</idno><idno type="wicri:Area/PubMed/Checkpoint">001273</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001273</idno><idno type="wicri:Area/Ncbi/Merge">003729</idno><idno type="wicri:Area/Ncbi/Curation">003729</idno><idno type="wicri:Area/Ncbi/Checkpoint">003729</idno><idno type="wicri:Area/Main/Merge">000543</idno><idno type="wicri:Area/Main/Curation">000548</idno><idno type="wicri:Area/Main/Exploration">000548</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction.</title><author><name sortKey="Gandhi, Parul U" sort="Gandhi, Parul U" uniqKey="Gandhi P" first="Parul U" last="Gandhi">Parul U. Gandhi</name><affiliation wicri:level="2"><nlm:affiliation>Section of Cardiovascular Medicine, VA Connecticut, West Haven, Connecticut; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Connecticut</region></placeName><wicri:cityArea>Section of Cardiovascular Medicine, VA Connecticut, West Haven, Connecticut; Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven</wicri:cityArea></affiliation></author><author><name sortKey="Chow, Sheryl L" sort="Chow, Sheryl L" uniqKey="Chow S" first="Sheryl L" last="Chow">Sheryl L. Chow</name><affiliation wicri:level="2"><nlm:affiliation>Western University of Health Sciences, Pomona, California.</nlm:affiliation><country>États-Unis</country><placeName><region type="state">Californie</region></placeName><wicri:cityArea>Western University of Health Sciences, Pomona</wicri:cityArea></affiliation></author><author><name sortKey="Rector, Thomas S" sort="Rector, Thomas S" uniqKey="Rector T" first="Thomas S" last="Rector">Thomas S. Rector</name><affiliation wicri:level="2"><nlm:affiliation>Veterans Affairs Medical Center, Minneapolis, Minnesota; University of Minnesota, Minneapolis, Minnesota.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Minnesota</region></placeName><wicri:cityArea>Veterans Affairs Medical Center, Minneapolis, Minnesota; University of Minnesota, Minneapolis</wicri:cityArea></affiliation></author><author><name sortKey="Krum, Henry" sort="Krum, Henry" uniqKey="Krum H" first="Henry" last="Krum">Henry Krum</name><affiliation wicri:level="3"><nlm:affiliation>CCRE Therapeutics, Monash University, Melbourne, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>CCRE Therapeutics, Monash University, Melbourne</wicri:regionArea><placeName><settlement type="city">Melbourne</settlement><region type="état">Victoria (État)</region></placeName></affiliation></author><author><name sortKey="Gaggin, Hanna K" sort="Gaggin, Hanna K" uniqKey="Gaggin H" first="Hanna K" last="Gaggin">Hanna K. Gaggin</name><affiliation wicri:level="2"><nlm:affiliation>Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Cardiology Division, Massachusetts General Hospital, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Mcmurray, John J" sort="Mcmurray, John J" uniqKey="Mcmurray J" first="John J" last="Mcmurray">John J. Mcmurray</name><affiliation wicri:level="1"><nlm:affiliation>British Heart Foundation Glasgow Cardiovascular Research Center, Glasgow, United Kingdom.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>British Heart Foundation Glasgow Cardiovascular Research Center, Glasgow</wicri:regionArea><wicri:noRegion>Glasgow</wicri:noRegion></affiliation></author><author><name sortKey="Zile, Michael R" sort="Zile, Michael R" uniqKey="Zile M" first="Michael R" last="Zile">Michael R. Zile</name><affiliation wicri:level="2"><nlm:affiliation>RHJ Department of Veterans Affairs Medical Center and Medical University of South Carolina, Charleston, South Carolina.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Caroline du Sud</region></placeName><wicri:cityArea>RHJ Department of Veterans Affairs Medical Center and Medical University of South Carolina, Charleston</wicri:cityArea></affiliation></author><author><name sortKey="Komajda, Michel" sort="Komajda, Michel" uniqKey="Komajda M" first="Michel" last="Komajda">Michel Komajda</name><affiliation wicri:level="3"><nlm:affiliation>Université Paris 6; Pitie Salpetriere Hospital, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université Paris 6; Pitie Salpetriere Hospital, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Mckelvie, Robert S" sort="Mckelvie, Robert S" uniqKey="Mckelvie R" first="Robert S" last="Mckelvie">Robert S. Mckelvie</name><affiliation wicri:level="1"><nlm:affiliation>Population Health Research Institute and McMaster University, Hamilton, Ontario, Canada.</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Population Health Research Institute and McMaster University, Hamilton, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Carson, Peter E" sort="Carson, Peter E" uniqKey="Carson P" first="Peter E" last="Carson">Peter E. Carson</name><affiliation wicri:level="2"><nlm:affiliation>Washington VAMC and Georgetown University, Washington, DC.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">District de Columbia</region></placeName><wicri:cityArea>Washington VAMC and Georgetown University, Washington</wicri:cityArea></affiliation></author><author><name sortKey="Januzzi, James L" sort="Januzzi, James L" uniqKey="Januzzi J" first="James L" last="Januzzi">James L. Januzzi</name><affiliation wicri:level="2"><nlm:affiliation>Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: jjanuzzi@partners.org.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Cardiology Division, Massachusetts General Hospital, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Anand, Inder S" sort="Anand, Inder S" uniqKey="Anand I" first="Inder S" last="Anand">Inder S. Anand</name><affiliation wicri:level="2"><nlm:affiliation>Veterans Affairs Medical Center, Minneapolis, Minnesota; University of Minnesota, Minneapolis, Minnesota.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Minnesota</region></placeName><wicri:cityArea>Veterans Affairs Medical Center, Minneapolis, Minnesota; University of Minnesota, Minneapolis</wicri:cityArea></affiliation></author></analytic><series><title level="j">Journal of cardiac failure</title><idno type="eISSN">1532-8414</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Angiotensin II Type 1 Receptor Blockers (therapeutic use)</term><term>Biphenyl Compounds (therapeutic use)</term><term>Cause of Death (trends)</term><term>Female</term><term>Follow-Up Studies</term><term>Heart Failure (blood)</term><term>Heart Failure (drug therapy)</term><term>Heart Failure (mortality)</term><term>Hospitalization (statistics & numerical data)</term><term>Humans</term><term>Insulin-Like Growth Factor Binding Proteins (blood)</term><term>Male</term><term>Prognosis</term><term>Risk Factors</term><term>Stroke Volume (physiology)</term><term>Survival Rate (trends)</term><term>Tetrazoles (therapeutic use)</term><term>Time Factors</term><term>United States (epidemiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antagonistes du récepteur de type 1 de l'angiotensine-II (usage thérapeutique)</term><term>Cause de décès (tendances)</term><term>Débit systolique (physiologie)</term><term>Défaillance cardiaque (mortalité)</term><term>Défaillance cardiaque (sang)</term><term>Défaillance cardiaque (traitement médicamenteux)</term><term>Dérivés du biphényle (usage thérapeutique)</term><term>Facteurs de risque</term><term>Facteurs temps</term><term>Femelle</term><term>Hospitalisation ()</term><term>Humains</term><term>Mâle</term><term>Pronostic</term><term>Protéines de liaison aux IGF (sang)</term><term>Sujet âgé</term><term>Taux de survie (tendances)</term><term>Tétrazoles (usage thérapeutique)</term><term>États-Unis d'Amérique (épidémiologie)</term><term>Études de suivi</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Insulin-Like Growth Factor Binding Proteins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Angiotensin II Type 1 Receptor Blockers</term><term>Biphenyl Compounds</term><term>Tetrazoles</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Heart Failure</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Heart Failure</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>United States</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Heart Failure</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Défaillance cardiaque</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Débit systolique</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Stroke Volume</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Défaillance cardiaque</term><term>Protéines de liaison aux IGF</term></keywords><keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Hospitalization</term></keywords><keywords scheme="MESH" qualifier="tendances" xml:lang="fr"><term>Cause de décès</term><term>Taux de survie</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Défaillance cardiaque</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Cause of Death</term><term>Survival Rate</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antagonistes du récepteur de type 1 de l'angiotensine-II</term><term>Dérivés du biphényle</term><term>Tétrazoles</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>États-Unis d'Amérique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Prognosis</term><term>Risk Factors</term><term>Time Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Facteurs de risque</term><term>Facteurs temps</term><term>Femelle</term><term>Hospitalisation</term><term>Humains</term><term>Mâle</term><term>Pronostic</term><term>Sujet âgé</term><term>Études de suivi</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The prognostic merit of insulin-like growth factor-binding protein 7 (IGFBP7) is unknown in heart failure and preserved ejection fraction (HFpEF).</div></front></TEI><affiliations><list><country><li>Australie</li><li>Canada</li><li>France</li><li>Royaume-Uni</li><li>États-Unis</li></country><region><li>Californie</li><li>Caroline du Sud</li><li>Connecticut</li><li>District de Columbia</li><li>Massachusetts</li><li>Minnesota</li><li>Victoria (État)</li><li>Île-de-France</li></region><settlement><li>Melbourne</li><li>Paris</li></settlement></list><tree><country name="États-Unis"><region name="Connecticut"><name sortKey="Gandhi, Parul U" sort="Gandhi, Parul U" uniqKey="Gandhi P" first="Parul U" last="Gandhi">Parul U. Gandhi</name></region><name sortKey="Anand, Inder S" sort="Anand, Inder S" uniqKey="Anand I" first="Inder S" last="Anand">Inder S. Anand</name><name sortKey="Carson, Peter E" sort="Carson, Peter E" uniqKey="Carson P" first="Peter E" last="Carson">Peter E. Carson</name><name sortKey="Chow, Sheryl L" sort="Chow, Sheryl L" uniqKey="Chow S" first="Sheryl L" last="Chow">Sheryl L. Chow</name><name sortKey="Gaggin, Hanna K" sort="Gaggin, Hanna K" uniqKey="Gaggin H" first="Hanna K" last="Gaggin">Hanna K. Gaggin</name><name sortKey="Januzzi, James L" sort="Januzzi, James L" uniqKey="Januzzi J" first="James L" last="Januzzi">James L. Januzzi</name><name sortKey="Rector, Thomas S" sort="Rector, Thomas S" uniqKey="Rector T" first="Thomas S" last="Rector">Thomas S. Rector</name><name sortKey="Zile, Michael R" sort="Zile, Michael R" uniqKey="Zile M" first="Michael R" last="Zile">Michael R. Zile</name></country><country name="Australie"><region name="Victoria (État)"><name sortKey="Krum, Henry" sort="Krum, Henry" uniqKey="Krum H" first="Henry" last="Krum">Henry Krum</name></region></country><country name="Royaume-Uni"><noRegion><name sortKey="Mcmurray, John J" sort="Mcmurray, John J" uniqKey="Mcmurray J" first="John J" last="Mcmurray">John J. Mcmurray</name></noRegion></country><country name="France"><region name="Île-de-France"><name sortKey="Komajda, Michel" sort="Komajda, Michel" uniqKey="Komajda M" first="Michel" last="Komajda">Michel Komajda</name></region></country><country name="Canada"><noRegion><name sortKey="Mckelvie, Robert S" sort="Mckelvie, Robert S" uniqKey="Mckelvie R" first="Robert S" last="Mckelvie">Robert S. Mckelvie</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000548 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000548 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:27317843
|texte= Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27317843" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |